ReviewPatient preference and adherence2018

Subcutaneous formulation of belimumab in treatment of systemic lupus erythematosus: a critical review with focus on safety and satisfaction.

Hamdy Ma Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.